ScholarIQanswers from OpenAlex

Role of immunotherapy and co-mutations on KRAS-mutant non- small cell lung cancer survival

PaperCitations, authors & open-access status

Role of immunotherapy and co-mutations on KRAS-mutant non- small cell lung cancer survival is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Role of immunotherapy and co-mutations on KRAS-mutant non- small cell lung cancer survival have?

ScholarIQcitation count

Role of immunotherapy and co-mutations on KRAS-mutant non- small cell lung cancer survival has 46 citations in the OpenAlex counts ScholarIQ stores.

When was Role of immunotherapy and co-mutations on KRAS-mutant non- small cell lung cancer survival published?

ScholarIQyear

Role of immunotherapy and co-mutations on KRAS-mutant non- small cell lung cancer survival has 2020 year in the ScholarIQ index.

What is the open-access status of Role of immunotherapy and co-mutations on KRAS-mutant non- small cell lung cancer survival?

ScholarIQoa status

Role of immunotherapy and co-mutations on KRAS-mutant non- small cell lung cancer survival has diamond oa status in the ScholarIQ index.

What is the DOI of Role of immunotherapy and co-mutations on KRAS-mutant non- small cell lung cancer survival?

ScholarIQdoi

The DOI for Role of immunotherapy and co-mutations on KRAS-mutant non- small cell lung cancer survival is on the source record.

What is the PMID of Role of immunotherapy and co-mutations on KRAS-mutant non- small cell lung cancer survival?

ScholarIQpmid

The PMID for Role of immunotherapy and co-mutations on KRAS-mutant non- small cell lung cancer survival is on the source record.

What is the OpenAlex record for Role of immunotherapy and co-mutations on KRAS-mutant non- small cell lung cancer survival?

ScholarIQopenalex

The OpenAlex for Role of immunotherapy and co-mutations on KRAS-mutant non- small cell lung cancer survival is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial